Role of costimulatory molecules in immune response of patients with cutaneous leishmaniasis

Microbes and Infection

Volumn 7, Issue 1, 2005, Pages 86-92

  Favali, Cecilia ^a   Costa, Dirceu ^a   Afonso, Lilian ^a   Conceição, Viviane ^a   Rosato, Andréa ^a   Oliveira, Fabiano ^a   Costa, Jackson ^a   Barral, Aldina ^a,b,c   Barral Netto, Manoel ^a,b,c   Brodskyn, Claudia Ida ^a,b,c  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^c Millenium Institute   (Brazil)

Author keywords

Cutaneous leishmaniasis; Cytokines; Immunomodulation

Indexed keywords

CD28 ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD8 ANTIGEN; COSTIMULATORY MOLECULE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; IMMUNOGLOBULIN; IMMUNOLOGIC FACTOR; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; PARASITE ANTIGEN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CELL STIMULATION; CELL SURFACE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSTIMULATION; LEISHMANIA; MOLECULAR INTERACTION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SKIN LEISHMANIASIS; SUPERNATANT; T LYMPHOCYTE;

EID: 20144388876     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micinf.2004.09.015     Document Type: Article

References (26)

1. T.R. Mosmann, and R.L. Coffman Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties Annu. Rev. Immunol. 7 1989 145 173
2. M. Barral-Netto, C.I. Brodskyn, and E.M. Carvalho A Barral, Human_leishmaniasis/cytokines.bahia.br Braz. J. Med. Biol. Res. 31 1998 149 155
3. I.S. Grewal, and R.A. Flavell CD40 and CD154 in cell-mediated immunity Annu. Rev. Immunol. 16 1998 111 135
4. N.L. Harris, and F. Ronchese The role of B7 costimulation in T-cell immunity Immunol. Cell Biol. 77 1999 304 311
5. F.A. Harding, J.G. McArthur, J.A. Gross, D.H. Raulet, and J.P. Allison CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones Nature 356 1992 607 609
6. D.B. Corry, S.L. Reiner, P.S. Linsley, and R.M. Locksley Differential effects of blockade of CD28-B7 on the development of Th1 or Th2 effector cells in experimental leishmaniasis J. Immunol. 153 1994 4142 4148
7. T.M. Foy, A. Aruffo, J. Bajorath, J.E. Buhlmann, and R.J. Noelle Immune regulation by CD40 and its ligand GP39 Annu. Rev. Immunol. 14 1996 591 617
8. K.A. Campbell, P.J. Ovendale, M.K. Kennedy, W.C. Fanslow, S.G. Reed, and C.R. Maliszewski CD40 ligand is required for protective cell-mediated immunity to Leishmania major Immunity 4 1996 283 289
9. C.I. Brodskyn, G.K. DeKrey, and R.G. Titus Influence of costimulatory molecules on immune response to Leishmania major by human cells in vitro Infect. Immun. 69 2001 665 672
10. C.I. de Oliveira, A. Bafica, F. Oliveira, C.B. Favali, T. Correa, L.A. Freitas, E. Nascimento, J.M. Costa, and A. Barral Clinical utility of polymerase chain reaction-based detection of Leishmania in the diagnosis of American cutaneous leishmaniasis Clin. Infect. Dis. 37 2003 e149 e153
11. O. Bacellar, C. Russo, and E.M. Carvalho Regulation of T cell response to Leishmania antigens by determinants of histocompatibility leukocyte class I and II molecules Braz. J. Med. Biol. Res. 31 1998 1575 1581
12. E.M. Carvalho, W.D. Johnson, E. Barreto, P.D. Marsden, J.L. Costa, and S. Reed Cell mediated immunity in American cutaneous and mucosal leishmaniasis J. Immunol. 135 1985 4144 4148
13. P.S. Yamauchi, J.R. Bleharski, K. Uyemura, J. Kim, P.A. Sieling, A. Miller, H. Brightbill, K. Schlienger, T.H. Rea, and R.L. Modlin A role for CD40-CD40 ligand interactions in the generation of type 1 cytokine responses in human leprosy J. Immunol. 165 2000 1506 1512
14. W.G. Ferlin, T. Von der Weid, F. Cottrez, D.A. Ferrick, R.L. Coffman, and M.C. Howard The induction of a protective response in Leishmania major-infected BALB/c mice with anti-CD40 mAb Eur. J. Immunol. 28 1998 525 531
15. H.W. Murray, B.Y. Rubin, and C.D. Rothermel Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine J. Clin. Invest. 72 1983 1506 1510
16. A. Ribeiro-de-Jesus, R.P. Almeida, H. Lessa, O. Bacellar, and E.M. Carvalho Cytokine profile and pathology in human leishmaniasis Braz. J. Med. Biol. Res. 31 1998 143 148
17. L.R. Antonelli, W.O. Dutra, R.P. Almeida, O. Bacellar, and K.J. Gollob Antigen specific correlations of cellular immune responses in human leishmaniasis suggests mechanisms for immunoregulation Clin. Exp. Immunol. 136 2004 341 348
18. S. Ajdary, M.H. Alimohammadian, M.B. Eslami, K. Kemp, and A. Kharazmi Comparison of the immune profile of nonhealing cutaneous leishmaniasis patients with those with active lesions and those who have recovered from infection Infect. Immun. 68 2000 1760 1764
19. M. Barral-Netto, A. Barral, C.E. Brownell, Y.A. Skeiky, L.R. Ellingsworth, and D.R. Twardzik Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism Science 257 1992 545 548
20. N.A. Gomes, C.R. Gattass, V. Barreto-De-Souza, M.E. Wilson, and G.A. DosReis TGF-beta mediates CTLA-4 suppression of cellular immunity in murine kalaazar J. Immunol. 164 2000 2001 2008
21. M. Martin, H. Schneider, A. Azouz, and C.E. Rudd Cytotoxic T lymphocyte antigen 4 and CD28 modulate cell surface raft expression in their regulation of T cell function J. Exp. Med. 194 2001 1675 1681
22. D.H. Munn, E. Shafizadeh, J.T. Attwood, I. Bondarev, A. Pashine, and A.L. Mellor Inhibition of T cell proliferation by macrophage tryptophan catabolism J. Exp. Med. 189 1999 1363 1372
23. F. Fallarino, U. Grohmann, C. Vacca, R. Bianchi, C. Orabona, A. Spreca, M.C. Fioretti, and P. Puccetti T cell apoptosis by tryptophan catabolism Cell Death Differ 9 2002 1069 1077
24. F.P. Heinzel, R.M. Rerko, and A.M. Hujer Underproduction of interleukin-12 in susceptible mice during progressive leishmaniasis is due to decreased CD40 activity Cell. Immunol. 184 1998 129 142
25. U.M. Padigel, P.J. Perrin, and J.P. Farrell The development of a Th1-type response and resistance to Leishmania major infection in the absence of CD40-CD40L costimulation J. Immunol. 167 2001 5874 5879
26. P. Zhou, and R.A. Seder CD40 ligand is not essential for induction of type 1 cytokine responses or protective immunity after primary or secondary infection with histoplasma capsulatum J. Exp. Med. 187 1998 1315 1324